Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Unique issues raised by drug benefit design.

Ernst R Berndt¹

¹Massachusetts Institute of Technology, Alfred P Sloan School of Management, Program on Technological Progress and Productivity Measurement, National Bureau of Economic Research, Cambridge, Massachusetts, USA.

Health Affairs (Project Hope)

|March 9, 2004

Summary

The pharmaceutical industry

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Auditing the prescription drug consumer price index in a changing marketplace.

Health economics·2024

Same author

Biosimilars And Follow-On Products In The United States: Adoption, Prices, And Users.

Health affairs (Project Hope)·2021

Same author

The geography of prescription pharmaceuticals supplied to the USA: levels, trends, and implications.

Journal of law and the biosciences·2021

Same author

FOUR FACTS CONCERNING COMPETITION IN U.S. GENERIC PRESCRIPTION DRUG MARKETS.

International journal of the economics of business·2020

Same author

The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines.

Medical care research and review : MCRR·2020

Same author

Comparison of Stakeholder Metrics for Traditional and Adaptive Development and Licensing Approaches to Drug Development.

Therapeutic innovation & regulatory science·2018

Area of Science:

Health economics
Pharmaceutical policy
Innovation economics

Background:

The pharmaceutical industry possesses unique characteristics distinguishing it from other healthcare sectors.
Balancing cost containment, quality of care, and innovation incentives in healthcare policy is challenging.

Purpose of the Study:

To analyze the distinct features of the pharmaceutical industry.
To explain the difficulties in formulating policies for healthcare costs, quality, and innovation.
To review Joseph Newhouse's proposed Medicare prescription drug benefit program.

Main Methods:

Perspective and critical analysis of the pharmaceutical sector.
Review and summary of existing policy proposals.

Main Results:

Unique industry features complicate policy development.
Simultaneous achievement of cost control, high quality, and innovation is difficult.
Newhouse's Medicare drug benefit proposal presents specific challenges.

Conclusions:

Understanding pharmaceutical industry specificities is crucial for effective policy.
Policy interventions must carefully consider the trade-offs between cost, quality, and innovation.
Further examination of Medicare prescription drug benefit designs is warranted.

Related Experiment Videos